key: cord-1050276-r1hcz5py
authors: Amgalan, Ariunzaya; Othman, Maha
title: Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered questions
date: 2020-05-06
journal: J Thromb Haemost
DOI: 10.1111/jth.14832
sha: 66b4adaf6949e372e652391d3e14458d1f8ce2d8
doc_id: 1050276
cord_uid: r1hcz5py

We read with enthusiasm the recent article by Tang et al. entitled "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia," which is a retrospective analysis of the coagulation profile of 183 patients admitted with pneumonia secondary to the 2019-nCoV (COVID-19).1 This article deals with a timely topic and brings up important points that need to be interrogated in future studies.

We read with enthusiasm the recent article by Tang Viruses can directly interact with platelets, thereby altering their count and/or function. 5, 6 Platelet-specific receptors known to interact with viruses are reported. 6 Various mechanisms were explained and are dependent on the virus type. These include: triggering systemic inflammation and clearance of activated platelets via splenic/liver macrophages and/or phagocytosis by neutrophils such as the case in influenza and rhinoviruses, 5 suppressing platelet production or enhancing platelet destruction such as the case in herpes and simian viruses, 5 and anti-viral antibodies cross-reacting with platelet surface integrins such as the case in adenovirus (platelet integrin GPIIb/IIIa). 5, 7 Platelets were found to express the Coxsackie adenovirus receptor (CAR); in-vitro and in-vivo studies showed direct adenovirus-platelet interactions, followed by platelet activation as evidenced by increased expression of P-selectin with subsequent formation of platelet-leukocyte aggregates and expression of leukocytes and endothelial cells' activation markers. 8, 9 Furthermore, the adenovirus-induced thrombocytopenia was found to be dependent on von 

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis

Disseminated intravascular coagulation

Platelets in immune response to virus and immunopathology of viral infections

Platelets and infection -An emerging role of platelets in viral infection

Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens

Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors

Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance

Human platelets express CAR with localization at the sites of intercellular interaction

Review: Viral infections and mechanisms of thrombosis and bleeding

Hematological findings in SARS patients and possible mechanisms (review)

Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)

Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia